CEE PMSS (Central Eastern European Post-Marketing Surveillance Study) First Presentation of Mirapexin in Parkinson Patients.

Trial Profile

CEE PMSS (Central Eastern European Post-Marketing Surveillance Study) First Presentation of Mirapexin in Parkinson Patients.

Completed
Phase of Trial: Phase IV

Latest Information Update: 11 Jun 2014

At a glance

  • Drugs Pramipexole (Primary)
  • Indications Parkinson's disease
  • Focus Therapeutic Use
  • Acronyms CEE-PMSS
  • Sponsors Boehringer Ingelheim
  • Most Recent Events

    • 21 Nov 2009 Actual initiation date changed from Jan 2006 to Feb 2006 and actual patient number changed from 2324 to 2448 as reported by ClinicalTrials.gov.
    • 27 Jan 2009 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top